CD8A and myelodysplastic syndrome: Compared to low-risk MDS, high-risk MDS is associated with the presence of dysfunctional NK cells, increased Tregs, increased cytotoxic CD8+ T cells, lower apoptosis and a poor response to immunosuppressive therapy [10].